Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide. (Q48514939)

12 February 2018

title

Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide. (English)

1 reference

12 February 2018

1 reference

Cameron JS

1

1 reference

12 February 2018

Chantler C

series ordinal

2

1 reference

12 February 2018

Ogg CS

series ordinal

3

1 reference

12 February 2018

White RH

series ordinal

4

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 October 1974

1 reference

12 February 2018

published in

The BMJ

1 reference

12 February 2018

volume

4

1 reference

12 February 2018

issue

5935

1 reference

12 February 2018

page(s)

7-11

1 reference

12 February 2018

Paired Trial of Cyclophosphamide and Prednisone in Children with Nephrosis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Augmented incidence of neoplasia in NZB-NZW mice treated with long-term cyclophosphamide.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Cytotoxic agents in childhood glomerulonephritis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Fatal systemic measles in a child receiving cyclophosphamide for nephrotic syndrome

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Cyclophosphamide and the prepubertal testis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Cyclophosphamide and reproductive function.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Risk of cancer in renal-transplant recipients.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Cyclophosphamide Therapy in the Nephrotic Syndrome in Childhood

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612099

Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children

14 August 2018

1 reference

12 December 2020

Cyclophosphamide and fatal varicella

1 reference

12 December 2020

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

1 reference

12 December 2020

Cyclophosphamide therapy in idiopathic nephrotic syndrome--a new treatment

1 reference

12 December 2020

Sterility and testicular atrophy related to cyclophosphamide therapy

1 reference

12 December 2020

Sterility and cyclophosphamide

1 reference

12 December 2020

Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome

1 reference

12 December 2020

Testicular atrophy in a prepubescent male after cyclophosphamide therapy

1 reference

12 December 2020

Cyclophosphamide and the prepubertal testis

1 reference

12 December 2020

Cyclophosphamide and the pubertal testis

1 reference

12 December 2020

Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome

1 reference

12 December 2020

Sterility and cyclophosphamide

1 reference

12 December 2020

Cyclophosphamide-Induced Ovarian Failure

1 reference

12 December 2020

Idiopathic nephrotic syndrome of childhood: cyclophosphamide induced conversion from steroid refractory to highly steroid sensitive disease

1 reference

12 December 2020

Development of reticulum cell sarcoma during cyclophosphamide therapy

1 reference

12 December 2020

EXPERIENCE WITH ALKYLATING AGENTS IN THE TREATMENT OF CHILDREN WITH THE NEPHROTIC SYNDROME

1 reference

12 December 2020

https://api.fatcat.wiki/v0/release/5u2gabdnnbgpnbg6bqy2rysc3a

Identifiers

1 reference

30 July 2022

release_5u2gabdnnbgpnbg6bqy2rysc3a

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5u2gabdnnbgpnbg6bqy2rysc3a

30 July 2022

https://api.fatcat.wiki/v0/release/5u2gabdnnbgpnbg6bqy2rysc3a

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/5u2gabdnnbgpnbg6bqy2rysc3a

1 reference

30 July 2022